Literature DB >> 23758338

Psychological distress and poor quality of life in patients with central serous chorioretinopathy.

Alparslan Sahin1, Yasin Bez, Mehmet Cemal Kaya, Fatih Mehmet Türkcü, Muhammed Sahin, Harun Yüksel.   

Abstract

PURPOSE: We aimed to compare the mental health and quality of life (QoL) between central serous chorioretinopathy (CSCR) patients and the control subjects.
METHODS: Thirty consecutive patients presenting with CSCR and age-gender-matched 30 healthy control subjects filled in the following standardized questionnaires: Symptom Checklist 90-R (SCL 90-R) and Short Form 36 (SF-36). Age, gender, and ocular clinical findings were recorded.
RESULTS: According to SCL-90-R, all scores were significantly higher in the CSCR group when compared to the control group. The patients with CSCR reported significantly lower levels of QoL, except bodily pain.
CONCLUSION: Our results indicated that CSCR patients have poorer QoL and more psychological problems. CSCR patients may benefit from psychosocial support and interventions.

Entities:  

Mesh:

Year:  2013        PMID: 23758338     DOI: 10.3109/08820538.2013.793728

Source DB:  PubMed          Journal:  Semin Ophthalmol        ISSN: 0882-0538            Impact factor:   1.975


  15 in total

1.  A novel mutation of sgk-1 gene in central serous chorioretinopathy.

Authors:  Mahmut Akyol; Muhammet Kazım Erol; Ozdemir Ozdemir; Deniz Turgut Coban; Ahmet Burak Bilgin; Esin Sogutlu Sari; Elif Betul Turkoglu
Journal:  Int J Ophthalmol       Date:  2015-02-18       Impact factor: 1.779

2.  Relationship between mean platelet volume and central serous chorioretinopathy.

Authors:  Ayhan Dursun; Mustafa Ilker Toker; Ayşe Vural Ozec; Erman Bozali; Kadir Kirboga; Feyza Gulac Dursun; Haydar Erdogan; Aysen Topalkara; Mustafa Kemal Arici
Journal:  Int Ophthalmol       Date:  2016-04-25       Impact factor: 2.031

3.  CONCURRENT IDIOPATHIC MACULAR TELANGIECTASIA TYPE 2 AND CENTRAL SEROUS CHORIORETINOPATHY.

Authors:  Alexandre Matet; Suzanne Yzer; Emily Y Chew; Alejandra Daruich; Francine Behar-Cohen; Richard F Spaide
Journal:  Retina       Date:  2018-01       Impact factor: 4.256

4.  Quality of life of patients with central serous chorioretinopathy - a major cause of vision threat among middle-aged individuals.

Authors:  Izabella Karska-Basta; Weronika Pociej-Marciak; Michał Chrząszcz; Katarzyna Żuber-Łaskawiec; Marek Sanak; Bożena Romanowska-Dixon
Journal:  Arch Med Sci       Date:  2020-01-29       Impact factor: 3.318

5.  High social anxiety and poor quality of life in patients with pulmonary tuberculosis.

Authors:  Erkan Kibrisli; Yasin Bez; Ahmet Yilmaz; Hamza Aslanhan; Mahsuk Taylan; Halide Kaya; Abdullah Cetin Tanrikulu; Ozlem Abakay
Journal:  Medicine (Baltimore)       Date:  2015-01       Impact factor: 1.889

6.  In patients suffering from idiopathic central serous chorioretinopathy, anxiety scores are higher than in healthy controls, but do not vary according to sex or repeated central serous chorioretinopathy.

Authors:  Nooshin Bazzazi; Mohammad Ahmadpanah; Siamak Akbarzadeh; Mohammad Ali Seif Rabiei; Edith Holsboer-Trachsler; Serge Brand
Journal:  Neuropsychiatr Dis Treat       Date:  2015-04-28       Impact factor: 2.570

7.  Effect of half adult dose of oral Rifampicin (300mg) in patients with idiopathic central serous chorioretinopathy.

Authors:  Muhammad Saim Khan; Murtaza Sameen; Arshad Ali Lodhi; Munawar Ahmed; Noman Ahmed; Mustafa Kamal; Sameen Afzal Junejo
Journal:  Pak J Med Sci       Date:  2016 Sep-Oct       Impact factor: 1.088

8.  Association of Central Serous Chorioretinopathy with Psychosocial Factors is Dependent on Its Phase and Subtype.

Authors:  Yong Kyu Kim; Se Joon Woo; Kyu Hyung Park; Yeon Kyung Chi; Ji Won Han; Ki Woong Kim
Journal:  Korean J Ophthalmol       Date:  2018-08

Review 9.  Advances in the treatment of central serous chorioretinopathy.

Authors:  Marwan A Abouammoh
Journal:  Saudi J Ophthalmol       Date:  2015-01-24

10.  Selective Retina Therapy with Real-Time Feedback-Controlled Dosimetry for Treating Acute Idiopathic Central Serous Chorioretinopathy in Korean Patients.

Authors:  Ye Ji Kim; Youn Gon Lee; Dong Won Lee; Jae Hui Kim
Journal:  J Ophthalmol       Date:  2018-02-06       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.